Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55.1Revenue $M6.6Net Margin (%)--Altman Z-Score-11.8
Enterprise Value $M-26.2EPS $-0.6Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.0Pre-tax Margin (%)--Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio3.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-77.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-118.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M138ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNTA

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SNTAFirst Eagle Investment 2012-06-30 Sold Out -0.0035%$3.71 - $7.79
$ 0.40-92%Sold Out0
SNTAFirst Eagle Investment 2012-03-31 Buy $4.22 - $5.66
$ 0.40-91%New holding200,000
SNTAMichael Price 2011-06-30 Sold Out -0.1%$4.45 - $6.23
$ 0.40-93%Sold Out0
SNTAMichael Price 2010-06-30 Buy 0.07%$2.67 - $4.79
$ 0.40-89%New holding118,058
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNTA is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

SNTA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Gollust Keith RDirector 2015-12-14Sell600,000$0.3514.29view
Gollust Keith RDirector 2015-12-09Sell745,892$0.385.26view
Kovner BruceDirector, 10% Owner 2015-12-08Sell1,523,346$0.378.11view
Kovner BruceDirector, 10% Owner 2015-12-03Sell1,430,753$0.43-6.98view
Kovner BruceDirector, 10% Owner 2015-11-30Sell3,078,820$0.48-16.67view
Kovner BruceDirector, 10% Owner 2015-11-24Sell1,173,582$0.44-9.09view
Kovner BruceDirector, 10% Owner 2015-11-20Sell1,513,088$0.49-18.37view
Kovner BruceDirector, 10% Owner 2015-11-17Sell1,223,936$0.43-6.98view
Gollust Keith RDirector 2015-11-17Sell100,000$0.41-2.44view
Kovner BruceDirector, 10% Owner 2015-11-12Sell5,436,673$0.55-27.27view

Quarterly/Annual Reports about SNTA:

News about SNTA:

Articles On GuruFocus.com
Insiders Sell Twitter and Cannabis Science, Buy DSW and WhiteHorse Dec 04 2015 
Stocks Both Gurus and Company Insiders Are Buying Jun 18 2015 
Insider Buys: FULL, FMI and SNTA Apr 10 2015 
Weekly 3-Year Low Highlights: NSR, ELRC, PLPC, SNTA Feb 16 2015 
5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
5-year lows: Synta Pharmaceuticals Inc, Rex Energy Corp, Petroquest Energy Inc, and Liquidity Servic Jan 11 2015 
5-year lows: Synta Pharmaceuticals Inc, Exelixis Inc, Entropic Communications Inc, and Aeropostale I Dec 28 2014 
Top 4 Insider Buys of Last Week Jun 10 2013 
Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI Jul 07 2012 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 

More From Other Websites
SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Termination of a Material Definitive Agreement,... Apr 22 2016
The Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen Apr 21 2016
Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal Apr 20 2016
Synta Pharmaceuticals Corp (SNTA): Billionaire Bruce Kovner Buys More Shares Apr 17 2016
Synta Stock Up on Merger Deal with Madrigal Pharmaceuticals Apr 15 2016
VKTX: Positive Phase 1b Data Presented for VK2809 in Hypercholestermic Patients; Recent M&A Activity... Apr 15 2016
Synta's marriage with Pennsylvania drugmaker spurred by actual marriage Apr 15 2016
SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 15 2016
SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 14 2016
$60M deal: Montco and Massachusetts biopharm firms to merge Apr 14 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and... Apr 14 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and... Apr 14 2016
SYNTA PHARMACEUTICALS CORP Files SEC form 10-K, Annual Report Mar 15 2016
What's in Store for Synta (SNTA) this Earnings Season? Mar 08 2016
SYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Mar 01 2016
Edited Transcript of SNTA earnings conference call or presentation 6-Nov-14 3:00pm GMT Feb 29 2016
​Two local biotechs that are now valued lower than their bank accounts Feb 12 2016
This Company is Up +400% in a Month Jan 07 2016
4 Small Cap NASDAQ/NYSE Stocks Trading With Heavy Volume Dec 15 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)